Tiffany Jones-Smith is the CEO of the Texas Kidney Foundation. As a people connector, with over 20 years of experience working in the c-suite of businesses, she has a reputation for opening the lines of communication between clients, organizations and businesses. She leverages influence and experience to form strategic alliances.

Jones-Smith is the host of the popular 930 AM radio show and VLOG On the Record with Tiffany. She uses her platform to explore healthcare topics, social issues and community heroes.

Jones-Smith was recently appointed by Governor Greg Abbott to the Texas Chronic Kidney Disease Task Force. She also belongs to the We Work for Health Texas Coalition, Honor the Gift Campaign, SAAACAM, San Antonio Business Journal Leadership Trust, American Association of Kidney Patients, and the San Antonio Hispanic Chamber of Commerce.

She holds a Public Leadership Credential from Harvard Business School Online along with a BA in Journalism and Foreign Service from Baylor University and a certificate in Italian studies from L’Universita per Stranieri, in Perugia, Italy. Tiffany attended high school at Mary Mount International School in Rome, Italy.

Tiffany is an entrepreneur, journalist, and healthcare advocate. According to Smith, “The United States has a broken healthcare system. We need a system with compensation models that are outcomes based.”

She strives to close the gap in healthcare disparities by addressing obesity, diabetes, hypertension and social determinants of health. She believes an ideal system would be data driven with emphasis on positive patient outcomes. She believes prevention and early disease detection are essential first steps to creating a healthy community. There are 140 million Americans living below the poverty line, addressing healthcare outcomes is her priority.

As a writer and advocate, Jones-Smith has a wealth of professional experience. She has been published in national, state and local journals. Her recent work is a research paper authored with 18 colleagues as a member of the APOL1 in Chronic Kidney Disease (CKD) Delphi Consensus, a group of investigators dedicated to the study of APOL1, the first CKD genetic link to descendants of West Sub-Saharan Africa.

Delphi consensus and systematic review on diagnosis, education and care of patients with APOL1-associated nephropathy will be published in 2020.

Jones-Smith also serves as the President and Chief Executive Officer of Dynamic Life Press